Gregory Roscoe, DMD
Otolaryngology · du Bois, PANPI 1124109335
Payments from drug & device makers
Across 51 payments — averaging $146.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Medical Device Business Services, Inc.$2K
- Medtronic$1K
- Acclarent, Inc$1K
- Inspire Medical Systems, Inc.$157
- Davol Inc.$147
- plus $149 from 7 others
What the payments were for
- Travel & lodging$5,27971%
- Food & beverage$1,17116%
- Education$1,03314%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $2,615 |
| Medical Device Business Services, Inc. | 8 | $2,084 |
| Medtronic | 6 | $1,208 |
| Acclarent, Inc | 9 | $1,126 |
| Inspire Medical Systems, Inc. | 5 | $157 |
| Davol Inc. | 1 | $147 |
| Johnson & Johnson | 1 | $28 |
| Alk-abello, Inc | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Smith+Nephew | 1 | $20 |
| Sanofi | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$2,387
- StealthStation$1,159
- ARISTA AH FLEXITIP$147
- XPRESS ENT DILATION SYSTEM$115
How this compares
$7,486 in reported general payments places this provider in the 85th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 70 | $1,110 |
| Levocetirizine Dihydrochloride | 28 | $420 |
| Omeprazole | 23 | $279 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 11 | $269 |
| Fluticasone Propionate | 19 | $260 |
| Dexamethasone | 16 | $245 |
| Ofloxacin | 14 | $222 |
| Pantoprazole Sodium | 13 | $197 |
| Cephalexin | 26 | $169 |
| Azithromycin | 22 | $73 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in du Bois
- Nancy SnydermanPhiladelphia$4.5M
- Joseph CurryPhiladelphia$2M
- David YenBethlehem$2M
- Stella LeePittsburgh$825K
- John GermillerPhiladelphia$825K
- Adam LuginbuhlPhiladelphia$745K
- Neerav GoyalHershey$640K
- David KennedyPhiladelphia$603K
- Richard SterlingPhiladelphia$378K
- Mauritis BoonPhiladelphia$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.